Galectin Therapeutics
GALT
GALT
59 hedge funds and large institutions have $11.3M invested in Galectin Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
Holders
59
Holding in Top 10
–
Calls
$327K
Puts
$188K
Top Buyers
| 1 | +$29K | |
| 2 | +$28.8K | |
| 3 | +$22K | |
| 4 |
VF
Virtu Financial
New York
|
+$21K |
| 5 |
Mariner
Overland Park,
Kansas
|
+$19K |
Top Sellers
| 1 | -$53.5K | |
| 2 | -$36K | |
| 3 | -$34.6K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$28.4K |
| 5 |
Millennium Management
New York
|
-$27K |